Health
Moffitt researchers reveal why some ovarian cancer patients evolve better than others – News-Medical.Net
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed….
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs.
In a new article published in Nature, Moffitt Cancer Center…
-
Noosa News15 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News21 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Noosa News8 hours agoItalian Film Festival, Brisbane: All the Details
-
Business20 hours agoAre BHP shares are buy after its results?